Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
-500.68%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 816 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Decoy Therapeutics Inc.
Market Cap
$846148.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$848569.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-935.37%
5Y Avg
-623.58%
Market Cap
$854360.00
Operating Margin
N/A
TTM Avg
-409.01%
3Y Avg
-308.21%
5Y Avg
-246.38%
Market Cap
$859749.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$880215.00
Operating Margin
-14.71%
TTM Avg
-14.51%
3Y Avg
-62.12%
5Y Avg
-354.09%
Market Cap
$801835.00
Operating Margin
N/A
TTM Avg
-1.14%
3Y Avg
-4.66%
5Y Avg
-4.48%
Market Cap
$901902.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$669223.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.02M
Operating Margin
-312016.95%
TTM Avg
-156008.48%
3Y Avg
-78004.24%
5Y Avg
-62403.39%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $846148.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $848569.00 | 0.00% | 0.00% | -935.37% | -623.58% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $854360.00 | N/A | -409.01% | -308.21% | -246.38% |
| Bone Biologics Corporation (BBLG)vs › | $859749.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $880215.00 | -14.71% | -14.51% | -62.12% | -354.09% |
| Ridgetech, Inc. (RDGT)vs › | $801835.00 | N/A | -1.14% | -4.66% | -4.48% |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| CDT Equity Inc. (CDT)vs › | $669223.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -312016.95% | -156008.48% | -78004.24% | -62403.39% |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 225.24% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -545.48% |
| 2021-03-31 | -142.23% |
| 2020-12-31 | -118.85% |
| 2020-09-30 | -127.59% |
| 2020-06-30 | -138.50% |
| 2020-03-31 | -209.17% |
| 2019-12-31 | -198.33% |
| 2019-09-30 | -429.76% |
| 2019-06-30 | -156.08% |
| 2019-03-31 | -2137.27% |
| 2018-12-31 | -1239.45% |
| 2018-09-30 | -1062.42% |
| 2018-06-30 | -3708.19% |
| 2018-03-31 | -4638.10% |
| 2017-12-31 | -2861.44% |
| 2017-09-30 | -2275.01% |
| 2017-06-30 | -2645.71% |
| 2017-03-31 | -3441.09% |
| 2016-12-31 | -2671.18% |
| 2016-09-30 | -1791.97% |
| 2016-06-30 | -10179.66% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
